Home > A. Molecular pathology > MUC1
MUC1
MIM.158340 1q21
Monday 23 August 2004
mucin-1, epithelial membrane antigen, EMA; CD227, MUC1 and episialin
PO | WP |
Definition: Large cell surface mucin glycoprotein expressed by most glandular and ductal epithelial cells and some hematopoietic cells.
Images
Invasive micropapillary carcinoma of the breast and its reversed apical pattern of MUC1 expression
Functions
Normally acts as barrier to apical surface of epithelial cells, playing a protective and regulatory role
Inhibits formation of E-cadherin - beta-catenin complex
Pathology
Micropapillary carcinoma may be due to reversal in cell polarity of MUC1, changing from apical surface (normal) to stroma-facing surface (micropapillary carcinoma, Mod Pathol 2004;17:1045); partial reverse cell polarity may identify breast carcinomas that represent part of spectrum of invasive micropapillary carcinoma but lack its morphology (Am J Surg Pathol 2010;34:1637)
Reactive gastropathy associated with loss of MUC1 expression in 67% of cases, may play a role in development of its serrated profile (Arch Pathol Lab Med 2007;131:86)
Expression in tumors
adenocarcinomas
- Highly expressed by most adenocarcinomas
- associated with poor prognosis (Hum Pathol 1995;26:432)
- Shed into the bloodstream of adenocarcinoma patients, used in commercial serum tumor marker assays (CA15-3)
mammary carcinomas
- In breast cancer, aberrant cytoplasmic and membranous localization (associated with micropapillary subtype) is associated with poor outcome (Mod Pathol 2005;18:1295)
meningioma
Paget disease (Am J Surg Pathol 2001;25:1469)
Hodgkin lymphoma with nodular lymphocytic predominance (Popemma paragranuloma)
- Popcorn cell can be EMA+
Adenocarcinomas (breast, colorectal, pancreatic, other)
Carcinoid tumor
chordoma
Choriocarcinoma
Desmoplastic small round cell tumor
Epithelioid sarcoma
Follicular dendritic cell sarcoma, interdigitating dendritic cell / reticulum cell sarcoma
Lung: type II pneumocyte lesions (type II cell hyperplasia, dysplastic type II cells, apical alveolar hyperplasia)
Lymphomas
- anaplastic large cell lymphoma (ALCL)
- diffuse large B-cell lymphoma (variable) (DLBCL)
- Hodgkin lymphoma with nodular lymphocytic predominance (+/-)
- plasmablastic lymphoma
- primary effusion lymphoma
- myeloma
- plasmacytoma
meningioma
mesotheliomas (epithelioid mesothelioma - peripheral positivity)
Paget’s disease
perineurioma
renal cell carcinoma
synovial sarcoma (epithelial areas)
thymic carcinoma (often)
Negative tumors
Myoepithelial cells
adrenal cortical carcinoma
hepatocellular carcinoma
germ cell tumors (except choriocarcinoma)
acquired cystic disease associated renal cell carcinoma
leiomyosarcoma (usually), liposarcoma
melanoma
neuroblastoma
paraganglioma
solitary fibrous tumor
Diagnostic use
In breast and bladder micropapillary carcinoma, MUC1 stains stroma-facing surface of cell clusters [basal], which accentuates outlines of micropapillary units to form a distinct band on this surface
Distinguish systemic anaplastic large cell lymphoma (MUC1+) from cutaneous anaplastic large cell lymphoma (usually MUC1-, Am J Surg Pathol 2008;32:1421)
Biomarker
MUC1 / Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma. (27481516)
Open references
Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma. Lappi-Blanco E, Mäkinen JM, Lehtonen S, Karvonen H, Sormunen R, Laitakari K, Johnson S, Mäkitaro R, Bloigu R, Kaarteenaho R.
Tumour Biol. 2016 Oct;37(10):13811-13820.
PMID: 27481516